Everest Medicines (云顶新耀) IPO: A Hot Deal Lacks Valuation Support
Everest raised HKD 3,281 million (USD 423\m) from its global offering and will list on the Hong Kong Stock Exchange tomorrow.
592 Views
ECM Weekly (4 October 2020) - JD Health, MINISO, Everest Med, Weihai Comm Bank, JD Digits
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...
362 Views
Everest Medicines IPO: Valuation Insights
Ocumension Therapeutics (1477 HK) is a China-based ophthalmic pharmaceutical company dedicated to identifying, developing and commercializing...
622 Views
Everest Medicines (云顶新耀) IPO: Overvalued for the Portfolio but Sentiment Is Strong
Everest Medicines is a China-based biotech company with late-stage drug candidates in-licensed from partner pharmaceutical companies and biotechs....
380 Views
ECM Weekly (27 September 2020) - Ant Group, Chindata, SCG Packaging, JHBP/Genor, Neuedu, UTI AMC
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Deal...
367 Views